Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 12,949-12,960 of 23,847
Drug study icon
CompletedNCT02477280

Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Västerås
Addiction, ADHDDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
Sweden
Sponsor
Region Västmanland
Condition
Addiction, ADHD
Other study type icon
CompletedEUCTR 2013-005451-32

Effects of F17464 in acute exacerbation of schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

In Hungary
SchizophreniaOther
Countries
Hungary, Latvia, Romania
Sponsor
Pierre Fabre Médicament represented by the Institut de Recherche Pierre Fabre (IRPF)
Condition
Schizophrenia
Drug study icon
CompletedNCT01100775

Effects of Galantamine on Cognition

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Baltimore
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.